Evonik to retain specialty monomers division after methacrylates divestment
Katherine Sale
25-Sep-2018
LONDON (ICIS)–Evonik has decided to retain its specialty monomers division following the anticipated divestment of its methyl methacrylate (MMA) and polymethyl methacrylate (PMMA) business units, according to a letter to customers seen by ICIS on Tuesday.
The
company announced in March this year that it is
considering spinning off the divisions, with
any potential sale potentially fetching
a price
tag of €1.8bn, according to market
analysts.
The specialty monomers division had been expected to be part of the carve-out.
“Evonik’s experience has shown that its specialty methacrylates and its oil additives businesses complement each other,” said the producer.
“The group [with branded name] Visiomer specialty monomers from the Application Monomers product line will be integrated into the Evonik Resource Efficiency segment.”
Evonik’s delivery obligations remain in place, it told its customers.
Pictured: Evonik’s MMA plant in
Shanghai
Source: Evonik
Global News + ICIS Chemical Business (ICB)
See the full picture, with unlimited access to ICIS chemicals news across all markets and regions, plus ICB, the industry-leading magazine for the chemicals industry.
Contact us
Partnering with ICIS unlocks a vision of a future you can trust and achieve. We leverage our unrivalled network of industry experts to deliver a comprehensive market view based on independent and reliable data, insight and analytics.
Contact us to learn how we can support you as you transact today and plan for tomorrow.
READ MORE
